Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases

被引:358
作者
Sonnweber, Thomas [1 ]
Pizzini, Alex [1 ]
Nairz, Manfred [1 ]
Weiss, Guenter [1 ]
Tancevski, Ivan [1 ]
机构
[1] Med Univ Innsbruck, Dept Internal Med 2, A-6020 Innsbruck, Austria
关键词
arachidonic acid; eicosanoids; metabolic disease; obesity; nonalcoholic fatty liver disease; diabetes; atherosclerosis; cardiovascular disease; cholesterol; FATTY LIVER-DISEASE; SOLUBLE EPOXIDE HYDROLASE; RECEPTOR ANTAGONIST MONTELUKAST; ASPIRIN-TRIGGERED LIPOXIN; LEUKOTRIENE B-4 RECEPTOR; INSULIN-RESISTANCE; EPOXYEICOSATRIENOIC ACIDS; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; LIPID MEDIATORS;
D O I
10.3390/ijms19113285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid and immune pathways are crucial in the pathophysiology of metabolic and cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to immunity and inflammation, thus holding a key role in the emergence and progression of frequent diseases such as obesity, diabetes, non-alcoholic fatty liver disease, and cardiovascular disease. We herein present a synopsis of AA metabolism in human health, tissue homeostasis, and immunity, and explore the role of the AA metabolome in diverse pathophysiological conditions and diseases.
引用
收藏
页数:26
相关论文
共 50 条
[41]   Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles [J].
Shoieb, Sherif M. ;
El-Ghiaty, Mahmoud A. ;
El-Kadi, Ayman O. S. .
EMERGENT MATERIALS, 2021, 4 (01) :265-277
[42]   Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation [J].
Kubala, Lukas ;
Schmelzer, Kara R. ;
Klinke, Anna ;
Kolarova, Hana ;
Baldus, Stephan ;
Hammock, Bruce D. ;
Eiserich, Jason P. .
FREE RADICAL BIOLOGY AND MEDICINE, 2010, 48 (10) :1311-1320
[43]   Irisin in metabolic diseases [J].
Stergios A. Polyzos ;
Athanasios D. Anastasilakis ;
Zoe A. Efstathiadou ;
Polyzois Makras ;
Nikolaos Perakakis ;
Jannis Kountouras ;
Christos S. Mantzoros .
Endocrine, 2018, 59 :260-274
[44]   ARACHIDONIC-ACID METABOLITES AND HEMODYNAMICS OF THE NEONATE [J].
REYES, JL .
PEDIATRIC NEPHROLOGY, 1993, 7 (06) :841-844
[45]   A Narrative Review of the Published Pre-Clinical Evaluations: Multiple Effects of Arachidonic Acid, its Metabolic Enzymes and Metabolites in Epilepsy [J].
Zeng, Meng-liu ;
Xu, Wei .
MOLECULAR NEUROBIOLOGY, 2025, 62 (01) :288-303
[46]   The role of the gut microbiome and its metabolites in metabolic diseases [J].
Wu, Jiayu ;
Wang, Kai ;
Wang, Xuemei ;
Pang, Yanli ;
Jiang, Changtao .
PROTEIN & CELL, 2021, 12 (05) :360-373
[47]   Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases [J].
Tong, Haihui ;
Zhang, Xuejun ;
Tan, Lingfang ;
Jin, Runming ;
Huang, Shilong ;
Li, Xin .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 870
[48]   Modulatory effects of Lactiplantibacillus plantarum on chronic metabolic diseases [J].
Tian, Lei ;
Zhao, Ruixiang ;
Xu, Xinyi ;
Zhou, Zhiwei ;
Xu, Xiaofang ;
Luo, Dongmei ;
Zhou, Zhiqiang ;
Liu, Yu ;
Kushmaro, Ariel ;
Marks, Robert S. ;
Dinnyes, Andras ;
Sun, Qun .
FOOD SCIENCE AND HUMAN WELLNESS, 2023, 12 (04) :959-974
[49]   Pharmacological effects of polydatin in the treatment of metabolic diseases: A review [J].
Luo, Jinli ;
Chen, Shuo ;
Wang, Li ;
Zhao, Xiaohua ;
Piao, Chunli .
PHYTOMEDICINE, 2022, 102
[50]   Promoting Lymphangiogenesis and Lymphatic Growth and Remodeling to Treat Cardiovascular and Metabolic Diseases [J].
Liu, Xiaolei ;
Cui, Kui ;
Wu, Hao ;
Li, Kathryn S. ;
Peng, Qianman ;
Wang, Donghai ;
Cowan, Douglas B. ;
Dixon, J. Brandon ;
Sathish Srinivasan, R. ;
Bielenberg, Diane R. ;
Chen, Kaifu ;
Wang, Da-Zhi ;
Chen, Yabing ;
Chen, Hong .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (01) :E1-E10